Evidence map›Paper›PMID 40492062›Full record

ArticlemedRxiv : the preprint server for health sciences2025

The role of tuberculosis symptoms in transmission risk to cell contacts in prisons.

Wanessa da Silva Peres Bezerra, Esther Jung, Mariana G Croda, Roberto Dias de Oliveira, Andrea da Silva Santos, Daniel Henrique Tsuha, Paulo Cesar Pereira Dos Santos, Eunice Atsuko Totumi Cunha, Julio Croda, Jason R Andrews

Registry-linked trialAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07520448 (Prevention and Mass Screening of TB in Prisons in Paraguay), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07520448 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Prevention and Mass Screening of TB in Prisons in Paraguay (PRESMAP-TB)

TypeinterventionalSponsorUniversidad Nacional de CaaguazuRan2026 to 2028Enrolled4,500ConditionsTuberculosis (TB), TB Infection, Prisoners, EpidemiologyArmsType 1 - Intensive Intervention, Type 2 - Optimized intervention, Type 3. Control.
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Wanessa da Silva Peres BezerraSchool of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.ORCID 0000-0002-5370-367X
Esther JungDivision of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0001-5073-8749
Mariana G CrodaSchool of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.ORCID 0000-0003-1436-9717
Roberto Dias de OliveiraState University of Mato Grosso do Sul, Dourados, Mato Grosso do Sul, Brazil.ORCID 0000-0001-7996-8011
Andrea da Silva SantosHealth Science Research Laboratory, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil.
Daniel Henrique TsuhaOswaldo Cruz Foundation, Campo Grande, Mato Grosso do Sul, Brazil.ORCID 0000-0002-0723-6142
Paulo Cesar Pereira Dos SantosSchool of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Eunice Atsuko Totumi CunhaLaboratory of Bacteriology of Central Laboratory, Health State Department of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.ORCID 0000-0002-5700-9044
Julio CrodaSchool of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.ORCID 0000-0002-6665-6825
Jason R AndrewsDivision of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0002-5967-251X

Funding

Strategies for tuberculosis control in prisonsR01AI130058 · NIAID · STANFORD UNIVERSITY · PI Jason Randolph Andrews, Julio Henrique Rosa Croda · 2017 to 2026
$5.8M
Characterizing infectiousness of subclinical TB and identifying novel early diagnostic strategies for preventing transmissionR01AI149620 · NIAID · STANFORD UNIVERSITY · PI ANDREWS, JASON RANDOLPH, CRODA, JULIO · 2020 to 2023
$617k
Mentoring patient-oriented translational research in tuberculosisK24AI182647 · NIAID · STANFORD UNIVERSITY · PI Jason Randolph Andrews · 2024 to 2026
$512k
NIAID NIH HHS K24 AI182647NIAID NIH HHS R01 AI130058NIAID NIH HHS R01 AI149620
6 · The paper itself

Abstract

Background: Understanding determinants of Methods: Between 2020 and 2022, we systematically screened PDL from three prisons in Brazil for TB by symptom assessment and sputum testing with Xpert MTB/RIF Ultra. We performed QuantiFERON-TB Gold Plus (QFT) testing among cell contacts of individuals with TB and in cells with no TB case identified. We evaluated the relationship between TB exposure (symptomatic, asymptomatic, none) and QFT positivity using Bayesian generalized linear mixed models. Results: We screened 7641 PDL for TB and identified 290 cases, yielding a prevalence of 3.8% (290/7641). After applying exclusion criteria, 686 participants were included for QFT analysis: 132 contacts of 42 individuals with symptomatic TB, 224 individuals exposed to 52 individuals with asymptomatic TB; 330 individuals with no recent cell exposure. Odds of QFT positivity were higher in symptomatic (adjusted odds ratio [aOR] 2.50, 95% CrI 1.51-4.16) and asymptomatic (aOR 1.61, 95% CrI 1.06-2.45) exposure groups compared to those unexposed. QFT positivity in contacts of symptomatic and asymptomatic TB did not differ (aOR 1.56, 95% CrI 0.92-2.63). Conclusions: Over half of individuals with TB lacked symptoms, and their contacts had increased risk of QFT positivity-comparable to contacts of symptomatic TB-compared with individuals without recent cell exposure. These findings underscore the importance of systematic screening for TB, irrespective of symptoms, to accelerate diagnosis and prevent transmission in high-burden settings.

Indexed as

Disease TransmissionInfectiousPublic Healthstatistics and numerical data

Identifiers

PMID40492062
PMCPMC12148278

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.